Critically ill patients and patients with haematological cancer are HIV-negative populations
at high risk of invasive fungal infections. In intensive-care units, candidaemia and intra …

The spectrum of aspergillosis encompasses a broad range of clinical entities, from
noninvasive forms, such as allergic bronchopulmonary aspergillosis (ABPA) and chronic …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Objective To provide an update to “Surviving Sepsis Campaign Guidelines for Management
of Sepsis and Septic Shock: 2012”. Design A consensus committee of 55 international …

Abstract The European Society for Clinical Microbiology and Infectious Diseases, the
European Confederation of Medical Mycology and the European Respiratory Society Joint …

Background Noninvasive diagnostic options are limited for invasive mold infections (IMIs).
We evaluated the performance of a plasma microbial cell-free DNA sequencing (mcfDNA …

Background Despite improved diagnostics, pulmonary pathogens in immunocompromised
children frequently evade detection, leading to significant mortality. Therefore, we aimed to …

Fungal infections are a rising threat to our immunocompromised patient population, as well
as other nonimmunocompromised patients with various medical conditions. However, little …

Invasive mould infections (IMIs), such as invasive aspergillosis or mucormycosis, are a
major cause of death in patients with haematological cancer and in patients receiving long …

Invasive fungal diseases (IFD) are a primary cause of morbidity and mortality in patients with
haematological malignancies. These infections are mostly life‐threatening and an early …